Caption Management, LLC Cure Vac N.V. Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $46,200 - $99,800	20,000 New	20,000 $68,000
Q1 2023 May 15, 2023	SELL	$6.38 - $12.5 $135,045 - $264,587	-21,167 Reduced 67.27%	10,297 $71,000
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $158,700 - $234,600	27,600 Added 714.29%	31,464 $189,000
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $24,212 - $49,331	3,237 Added 516.27%	3,864 $31,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $869,880 - $1.28 Million	-66,000 Reduced 99.06%	627 $9,000
Q1 2022 May 13, 2022	BUY	$14.73 - $35.25 $88,188 - $211,041	5,987 Added 9.87%	66,627 $1.31 Million
Q4 2021 Feb 11, 2022	BUY	$33.72 - $48.22 $1.78 Million - $2.54 Million	52,640 Added 658.0%	60,640 $2.08 Million
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $394,080 - $596,000	8,000 New	8,000 $437,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $769M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.